"Emtricitabine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A deoxycytidine analog and REVERSE TRANSCRIPTASE INHIBITOR with antiviral activity against HIV-1 and HEPATITIS B viruses. It is used to treat HIV INFECTIONS.
| Descriptor ID |
D000068679
|
| MeSH Number(s) |
D03.383.742.680.245.500.600 D13.570.230.329.525 D13.570.685.245.500.600
|
| Concept/Terms |
Emtricitabine- Emtricitabine
- Beta-L-2',3'-dideoxy-5-fluoro-3'-thiacytidine
- Beta L 2',3' dideoxy 5 fluoro 3' thiacytidine
|
Below are MeSH descriptors whose meaning is more general than "Emtricitabine".
Below are MeSH descriptors whose meaning is more specific than "Emtricitabine".
This graph shows the total number of publications written about "Emtricitabine" by people in this website by year, and whether "Emtricitabine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 0 | 1 | 1 |
| 2013 | 0 | 3 | 3 |
| 2014 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 13 | 14 | 27 |
| 2018 | 12 | 15 | 27 |
| 2019 | 5 | 3 | 8 |
| 2020 | 0 | 5 | 5 |
| 2021 | 0 | 4 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Emtricitabine" by people in Profiles.
-
Tenofovir-based PrEP for COVID-19: an untapped opportunity? AIDS. 2021 07 15; 35(9):1509-1511.
-
Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort. Clin Microbiol Infect. 2021 Nov; 27(11):1678-1684.
-
Failure to seroconvert after two doses of BNT162b2 SARS-CoV-2 vaccine in a patient with uncontrolled HIV. Lancet HIV. 2021 06; 8(6):e317-e318.
-
Early combination treatment with existing HIV antivirals: an effective treatment for COVID-19? Eur Rev Med Pharmacol Sci. 2021 Mar; 25(5):2435-2448.
-
Virtual HIV pre-exposure prophylaxis outpatient service in the era of COVID-19. Int J STD AIDS. 2021 01; 32(1):100-103.
-
Cases of coronavirus disease-2019 in HIV-infected transgender women. AIDS. 2020 07 15; 34(9):1435-1436.
-
Coronavirus disease 2019 and Pneumocystis jirovecii pneumonia: a diagnostic dilemma in HIV. AIDS. 2020 07 01; 34(8):1258-1260.
-
Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy : A Cohort Study. Ann Intern Med. 2020 10 06; 173(7):536-541.
-
Advance of promising targets and agents against COVID-19 in China. Drug Discov Today. 2020 05; 25(5):810-812.
-
HIV drug resistance in a cohort of HIV-infected MSM in the United States. AIDS. 2020 01 01; 34(1):91-101.